121 resultater (0,34414 sekunder)

Mærke

Butik

Pris (EUR)

Nulstil filter

Produkter
Fra
Butikker

Update Gastroenterology 2002 - - Bog - John Libbey Eurotext - Plusbog.dk

Update Gastroenterology 2001 - - Bog - John Libbey Eurotext - Plusbog.dk

Update Gastroenterology 2000 - - Bog - John Libbey Eurotext - Plusbog.dk

Novel Approaches in the Treatment of Gastrointestinal & Liver Disease - - Bog - John Libbey Eurotext - Plusbog.dk

Recent Advances in Pathophysiology of Gastro-Intestinal & Liver Diseases - J Gournay - Bog - John Libbey Eurotext - Plusbog.dk

Recent Advances in the Pathophysiology & Management of Inflammatory Bowel Diseases & Digestive Endocrine Tumors - - Bog - John Libbey Eurotext -

Recent Advances in the Pathogenesis of Gastrointestinal Bacterial Infections - - Bog - John Libbey Eurotext - Plusbog.dk

Transgenic Plants in Agriculture - Axel Kahn - Bog - John Libbey Eurotext - Plusbog.dk

Transgenic Plants in Agriculture - Axel Kahn - Bog - John Libbey Eurotext - Plusbog.dk

Axel Kahn''s book, published late in 1996, which provided an overview of the opinions expressed by the Commission of Biomolecular Engineering about genetically modified plants, was a great success. Given the scale and importance of the phenomenon, the French Ministry of Agriculture and publishers John Libbey Eurotext have decided to publish an English-language version of this fundamental book about the introduction and development of genetically modified plants. For some years now, plant biotechnology, especially genetic engineering, has enabled us to modify the cycle of plant production, strengthening resistance to weedkillers and pests, improving yields and quality, adapting plants to unfavourable environments and creating new species. In France, the Biomolecular Engineering Commission (CGB) is responsible for authorising the marketing of these modified products. Over the past ten years it has certified 450 new products for public consumption. This book, which is suitable for the general public, reports on the experience acquired by the CGB and the studies it has conducted: What are the potential risks associated with so-called transgenetic plants? Are there any undetectable phenomena involved? - How can such plants be produced more safely? Axel Kahn is a world-renowned geneticist and clinician, chaired the Biomolecular Engineering Commission until 1998. Here he explains the "philosophy" of the CGB, which has gained unrivalled experience in Europe, and sets out ethical and scientific guidelines for the use of genetic engineering techniques.

DKK 209.00
1

Health in France 1994-1998 - John Libbey Eurotext - Bog - John Libbey Eurotext - Plusbog.dk

Language - - Bog - John Libbey Eurotext - Plusbog.dk

Foregut - - Bog - John Libbey Eurotext - Plusbog.dk

Foregut - - Bog - John Libbey Eurotext - Plusbog.dk

Knowledge concerning oesophageal pathophysiology has until recently lagged far behind that of the pathophysiology of other portions of the gastrointestinal (GI) tract for reasons that still remain unclear. Yet, it is the fact that, at least until the last few decades, interest in the oesophagus was primarily based on pathologic anatomy. Even today, much remains to be learnt on the pathophysiology of oesophageal disease. The recent development of methods of studying both morphology and function of the oesophagus has resulted in a better understanding of normal and abnormal oesophageal patterns with a corresponding improvement in treatment, which is now physiologically, rather than anatomically based. As customary, the World OESO Congresses are planned to provide each time a thorough analysis of a specific topic in oesophageal disease. The 8th World Congress of OESO was devoted to the Foregut: Function and Dysfunction to emphasise the complex interaction between the oesophagus and the other portions of the upper GI tract, either in maintaining physiological function or in triggering oesophageal disease. The choice is a timely one because recent investigations have allowed new insights into the pathophysiology of these complex interactions to be gained. It is indeed becoming clear that there are intriguing pathophysiological abnormalities that account for upper GI symptoms and that more targeted therapy is needed to address the unmet clinical needs. Within this framework, specific sessions were devoted to disorders of secretion, of motility as well as of nutrition with a special emphasis on recent advances. Unlike some of the other publications, this volume does not merely represent the proceedings of an International Congress. With its now established and successful format, it collects the answers to 130 key questions, offered by 110 basic scientists and clinicians the world over, all of whom have personally contributed to the topic, in order to provide a glimpse of what may lie ahead. The easy-to-read format will allow the practising and busy physician to keep up efficiently with advances in diagnosis and therapy in this rapidly evolving field.

DKK 1159.00
1

Anxiety - - Bog - John Libbey Eurotext - Plusbog.dk

Dual Diagnosis - - Bog - John Libbey Eurotext - Plusbog.dk

Adrenal Cancer - - Bog - John Libbey Eurotext - Plusbog.dk

Neurodevelopmental Disorders - - Bog - John Libbey Eurotext - Plusbog.dk

Cytochrome P450 - - Bog - John Libbey Eurotext - Plusbog.dk

Gut Microflora - - Bog - John Libbey Eurotext - Plusbog.dk

Emerging Diseases - - Bog - John Libbey Eurotext - Plusbog.dk

Transfusion Medicine - - Bog - John Libbey Eurotext - Plusbog.dk

Ulcerative Colitis - - Bog - John Libbey Eurotext - Plusbog.dk

Parliaments & Screening - - Bog - John Libbey Eurotext - Plusbog.dk